1. Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence. Issue 9 (2nd September 2021) Authors: Santoni, Matteo; Iacovelli, Roberto; Colonna, Valentina; Klinz, Stephan; Mauri, Giorgio; Nuti, Marianna Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 9(2021) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗